NEWS
- Learn More About ADCs From Its Structure
- ADC Drug Trodelvy Shows Positive Efficacy In three Types of Cancers
- HER2 Targeted Therapies In Breast Cancer
- FDA Approval of ZYNLONTA™ (loncastuximab tesirine-lpyl) - First CD19-targeted ADC
- Blockbuster Drugs Approved by the FDA in August 2020
- FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer
- Overviews of the Antibody-drug conjugates (ADCs)
- ADCs Beyond Cancer: Emerging Therapeutic Potential
- ADC Market 2025: Rising Sales and Growing Phase III Pipelines
- Antibody-Degrader Conjugates (DACs): The Next Evolution of Antibody-Drug Conjugates